Quantitative 166Ho-microspheres SPECT derived from a dual-isotope acquisition with 99mTc-colloid is clinically feasible

PurposeAccurate dosimetry is essential in radioembolization. To this purpose, an automatic protocol for healthy liver dosimetry based on dual isotope (DI) SPECT imaging, combining holmium-166 (Ho-166)-microspheres, and technetium-99m (Tc-99m)-colloid was developed: Ho-166-microspheres used as scout and therapeutic particles, and Tc-99m-colloid to identify the healthy liver. DI SPECT allows for an automatic and accurate estimation of absorbed doses, introducing true personalized dosimetry. However, photon crosstalk between isotopes can compromise image quality. This study investigates the effect of Tc-99m downscatter on Ho-166 dosimetry, by comparing Ho-166-SPECT reconstructions of patient scans acquired before (Ho-166-only) and after additional administration of Tc-99m-colloid (Ho-166-DI).MethodsThe Ho-166-only and Ho-166-DI scans were performed in short succession by injecting Tc-99m-colloid on the scanner table. To compensate for Tc-99m downscatter, its influence was accounted for in the DI image reconstruction using energy window-based scatter correction methods. The qualitative assessment was performed by independent blinded comparison by two nuclear medicine physicians assessing 65 pairs of SPECT/CT. Inter-observer agreement was tested by Cohen's kappa coefficient. For the quantitative analysis, two volumes of interest within the liver, VOITUMOR, and VOIHEALTHY were manually delineated on the Ho-166-only reconstruction and transferred to the co-registered Ho-166-DI reconstruction. Absorbed dose within the resulting VOIs, and in the lungs (VOILUNGS), was calculated based on the administered therapeutic activity.ResultsThe qualitative assessment showed no distinct clinical preference for either Ho-166-only or Ho-166-DI SPECT (kappa = 0.093). Quantitative analysis indicated that the mean absorbed dose difference between Ho-166-DI and Ho-166-only was - 2.00 2.84Gy (median 27Gy; p value < 0.00001), - 5.27 8.99Gy (median 116Gy; p value = 0.00035), and 0.80 1.08Gy (median 3Gy; p value < 0.00001) for VOIHEALTHY, VOITUMOR, and VOILUNGS, respectively. The corresponding Pearson's correlation coefficient between Ho-166-only and Ho-166-DI for absorbed dose was 0.97, 0.99, and 0.82, respectively.Conclusion p id=Par The DI protocol enables automatic dosimetry with undiminished image quality and accuracy.Clinical trials p id=Par The clinical study mentioned is registered with Clinicaltrials.gov (NCT02067988) on 20 February 2014.